Cellular Senescence and COVID-19 Long-Hauler Syndrome

A Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil In the Treatment of Chronic Bronchitis

NCT00255983 ·Status: TERMINATED ·Phase: PHASE3

Evaluate the Efficacy and Safety of FB2001 for Inhalation in Patients With Mild to Moderate COVID-19

NCT05675072 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Safety and Pharmacokinetics of FBR-002 for the Treatment of Patients Hospitalized With COVID-19 in Need of Supplemental Oxygen and at Risk of Severe Outcome

NCT05279352 ·Status: UNKNOWN ·Phase: PHASE2

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

NCT05599191 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)

NCT01203943 ·Status: TERMINATED ·Phase: PHASE2

A Study to Assess the Effect of AZD5634 on Mucociliary Clearance, Safety, Tolerability and Pharmacokinetic Parameters in Patients With Cystic Fibrosis

NCT02950805 ·Status: COMPLETED ·Phase: PHASE1

Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF

NCT00650091 ·Status: COMPLETED ·Phase: PHASE3

Assessment of the Pharmacokinetics of BLU-5937 Extended Release Prototypes and a BLU-5937 Immediate Release Reference Formulation

NCT05570539 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Exosomes in Treating Chronic Cough After COVID-19

NCT05808400 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

A Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection (COVID-19)

NCT04888949 ·Status: COMPLETED ·Phase: PHASE2

A Phase I Study of iPS Cell Generation From Patients With COPD

NCT01860898 ·Status: COMPLETED ·Phase: NA

The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19

NCT04619680 ·Status: COMPLETED ·Phase: PHASE4

Study to Assess the Intrapulmonary Pharmacokinetics of SPR206 in Healthy Volunteers

NCT04868292 ·Status: COMPLETED ·Phase: PHASE1

Autologous Cellular Therapy With PRP-PC in Chronic Lung Diseases: An Observational Study LI-004

NCT05562843 ·Status: COMPLETED

Ozone Plasma on Lung Function and Inflammatory Parameters in Pulmonary Sequelae Associated With Coronavirus 19 Infection

NCT05089305 ·Status: UNKNOWN ·Phase: PHASE2

Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection

NCT04326036 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Phase 2 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes

NCT04409327 ·Status: TERMINATED ·Phase: PHASE2

A Phase 1 Study to Characterize the Effect of GS-5737 Enhancement of Mucociliary Clearance (MCC) in Healthy Subjects

NCT01793649 ·Status: TERMINATED ·Phase: PHASE1

A Trial of 2 Disease-Modifying Drugs (Metformin and N-acetylcysteine ) to Promote TB Lung Function Recovery

NCT07136987 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

NCT05975983 ·Status: RECRUITING ·Phase: PHASE2

The Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female Subjects

NCT03092102 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Ampion in Patients With Prolonged Respiratory Symptoms Due to COVID-19 (Long COVID)

NCT04880161 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis

NCT00930982 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety of MEDI2338 in Subjects With Chronic Obstructive Pulmonary Disease

NCT01322594 ·Status: COMPLETED ·Phase: PHASE1

The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects

NCT03502902 ·Status: COMPLETED ·Phase: PHASE1